Ghana · Delayed Price · Currency is GHS Intravenous Infusions Statistics
Total Valuation
GHSE:IIL has a market cap or net worth of GHS 214.04 million. The enterprise value is 223.03 million.
| Market Cap | 214.04M |
| Enterprise Value | 223.03M |
Important Dates
The next estimated earnings date is Monday, August 10, 2026.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
GHSE:IIL has 274.41 million shares outstanding. The number of shares has increased by 17.87% in one year.
| Current Share Class | 274.41M |
| Shares Outstanding | 274.41M |
| Shares Change (YoY) | +17.87% |
| Shares Change (QoQ) | +5.26% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 32.86 |
| PB Ratio | 13.15 |
| P/TBV Ratio | 13.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 34.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.76, with a Debt / Equity ratio of 0.57.
| Current Ratio | 0.76 |
| Quick Ratio | 0.46 |
| Debt / Equity | 0.57 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.79 |
| Interest Coverage | -43.04 |
Financial Efficiency
Return on equity (ROE) is -27.55% and return on invested capital (ROIC) is -20.88%.
| Return on Equity (ROE) | -27.55% |
| Return on Assets (ROA) | -8.21% |
| Return on Invested Capital (ROIC) | -20.88% |
| Return on Capital Employed (ROCE) | -24.36% |
| Weighted Average Cost of Capital (WACC) | 1.09% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.16 |
| Inventory Turnover | 0.84 |
Taxes
| Income Tax | -1.09M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1,500.00% in the last 52 weeks. The beta is -0.57, so GHSE:IIL's price volatility has been lower than the market average.
| Beta (5Y) | -0.57 |
| 52-Week Price Change | +1,500.00% |
| 50-Day Moving Average | 0.29 |
| 200-Day Moving Average | 0.11 |
| Relative Strength Index (RSI) | 61.33 |
| Average Volume (20 Days) | 479,468 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GHSE:IIL had revenue of GHS 6.51 million and -4.43 million in losses. Loss per share was -0.01.
| Revenue | 6.51M |
| Gross Profit | 2.25M |
| Operating Income | -5.28M |
| Pretax Income | -5.52M |
| Net Income | -4.43M |
| EBITDA | -4.76M |
| EBIT | -5.28M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 338,947 in cash and 9.33 million in debt, with a net cash position of -9.00 million or -0.03 per share.
| Cash & Cash Equivalents | 338,947 |
| Total Debt | 9.33M |
| Net Cash | -9.00M |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | 16.27M |
| Book Value Per Share | 0.05 |
| Working Capital | -3.95M |
Cash Flow
In the last 12 months, operating cash flow was -4.68 million and capital expenditures -524,457, giving a free cash flow of -5.20 million.
| Operating Cash Flow | -4.68M |
| Capital Expenditures | -524,457 |
| Depreciation & Amortization | 516,159 |
| Net Borrowing | 4.61M |
| Free Cash Flow | -5.20M |
| FCF Per Share | -0.02 |
Margins
Gross margin is 34.60%, with operating and profit margins of -81.01% and -68.01%.
| Gross Margin | 34.60% |
| Operating Margin | -81.01% |
| Pretax Margin | -84.67% |
| Profit Margin | -68.01% |
| EBITDA Margin | -73.08% |
| EBIT Margin | -81.01% |
| FCF Margin | n/a |
Dividends & Yields
GHSE:IIL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.87% |
| Shareholder Yield | -17.87% |
| Earnings Yield | -2.07% |
| FCF Yield | -2.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |